Which of the following is an adverse reaction to topical nasal steroid?
Rebound effect.
Local ulceration.
Increased nasal drainage.
Suppression of healing.
The Correct Answer is B
Choice A rationale
The rebound effect is typically associated with decongestants rather than topical nasal steroids. It occurs when nasal congestion worsens after stopping decongestant use.
Choice B rationale
Local ulceration is a potential adverse reaction to topical nasal steroids due to the localized irritation and thinning of the nasal mucosa with prolonged use.
Choice C rationale
Increased nasal drainage is not a common adverse reaction to topical nasal steroids. These medications typically reduce inflammation and decrease nasal drainage.
Choice D rationale
Suppression of healing is not an adverse reaction associated with topical nasal steroids. These drugs are more likely to reduce inflammation and promote healing of the nasal mucosa.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A rationale
Clonic-tonic muscle contraction is related to convulsions and seizures but does not accurately define epilepsy. Epilepsy is a neurological disorder characterized by recurrent seizures due to abnormal electrical activity in the brain.
Choice B rationale
Epilepsy involves abnormal electrical discharges in the brain, not in the muscles. Muscle contractions are a symptom of seizures, not the cause of epilepsy.
Choice C rationale
Epilepsy is not a single disease; it encompasses various conditions characterized by recurrent seizures. It is a spectrum of disorders with different causes and manifestations.
Choice D rationale
This choice accurately describes epilepsy as characterized by sudden, recurrent, and transient disturbances in brain function due to abnormal electrical discharges in the brain.
Correct Answer is C
Explanation
Choice A rationale
Working with animals is typically done in preclinical trials before phase I studies in humans and is not part of phase III drug evaluation studies.
Choice B rationale
Conducting research to determine the effectiveness of the drug is part of phase II studies. Phase III studies focus more on confirming effectiveness, monitoring side effects, and comparing it to commonly used treatments.
Choice C rationale
Monitoring and observing patients closely for adverse effects is a key responsibility in phase III drug evaluation studies. These studies involve a larger patient population to gather comprehensive safety and efficacy data.
Choice D rationale
Choosing appropriate patients to be involved in the study is primarily the responsibility of researchers and clinicians during the earlier phases of drug development, such as phase I and phase II studies.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.